Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice

(2015) Magdalena Mazagova et al.   FASEB JOURNAL

Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis

(2014) James H. Tabibian et al.   HEPATOLOGY

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

(2013) J. H. Tabibian et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cellular senescence and the senescent secretory phenotype: therapeutic opportunities

(2013) Tamara Tchkonia et al.   JOURNAL OF CLINICAL INVESTIGATION

Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography

(2013) James H Tabibian et al.   LABORATORY INVESTIGATION

Primary sclerosing cholangitis: a review and update on therapeutic developments

(2013) James H Tabibian et al.   Expert Review of Gastroenterology & Hepatology

Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis

(2013) James H. Tabibian et al.   Biomed Research International

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases

(2012) Henri Duboc et al.   GUT

Up-regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis

(2012) Jesús M. Banales et al.   HEPATOLOGY

Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function

(2012) T. Olszak et al.   SCIENCE

Interactions Between the Microbiota and the Immune System

(2012) L. V. Hooper et al.   SCIENCE

Inflammatory Bowel Disease Is Associated With Poor Outcomes of Patients With Primary Sclerosing Cholangitis

(2011) Jing Hieng Ngu et al.   Clinical Gastroenterology and Hepatology

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis

(2011) Tobias Mueller et al.   LIVER INTERNATIONAL

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

(2011) Tae-Won Kang et al.   NATURE

The intestinal microbiota and chronic disorders of the gut

(2011) Andrew W. DuPont et al.   Nature Reviews Gastroenterology & Hepatology

Outcomes and Diagnostic Challenges Posed by Incidental Cholangiocarcinoma After Liver Transplantation

(2011) Jason M. Ali et al.   TRANSPLANTATION

Gut microbiota and probiotics in chronic liver diseases

(2010) Claudia Cesaro et al.   DIGESTIVE AND LIVER DISEASE

Rapid in situ codetection of noncoding RNAs and proteins in cells and formalin-fixed paraffin-embedded tissue sections without protease treatment

(2010) Mariàngels de Planell-Saguer et al.   Nature Protocols

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis

(2009) Sanjay Y. Bangarulingam et al.   HEPATOLOGY

Diagnosis and management of primary sclerosing cholangitis

(2009) Roger Chapman et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

(2009)   JOURNAL OF HEPATOLOGY

Cellular senescence, ageing and disease

(2008) D. G. A. Burton   AGE

Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence

(2008) Juan C. Acosta et al.   CELL

The challenges in primary sclerosing cholangitis – Aetiopathogenesis, autoimmunity, management and malignancy

(2008) Tobias J. Weismüller et al.   JOURNAL OF HEPATOLOGY

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

(2008) Jean-Philippe Coppé et al.   PLOS BIOLOGY